ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681636 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681636; 2) Community: the network communities that were significantly associated with the response to NSC 681636; 3) Molecule: the relationships between components within communities and NSC 681636; 4) MDR: the compounds that were significantly associated with the NSC 681636.

NSC Compound Enrichment Correlation
NSC 753018 Null 0.0489393809599837 0.23486921
NSC 759857 Clofarabine (USAN) 0.0489393809599837 0.67653666
NSC 761814 3-(4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole 0.0489393809599837 0.01200032
NSC 762542 Null 0.0489393809599837 0.10077624
NSC 91745 9H-Purine, 6-[(1-methyl-4-nitroimidazol-5-yl)thio]-9-.beta.-D-ribofuranosyl-, compd. with ethyl alcohol (4:1) 0.0489393809599837 0.26349662
NSC 9612 Benzo[a]phenazoxonium, 5-(benzylamino)-9-(diethylamino)-, chloride (8CI) 0.0489393809599837 -0.14872924
NSC 683555 Camptothecin Derivative 1.79658531880938e-005 0.86722932
NSC 659687 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride 3.39349009784536e-005 0.61845415
NSC 681634 Camptothecin Derivative 3.40252996142934e-005 0.8867235
NSC 681635 Camptothecin Derivative 3.6295237294955e-006 0.88661612
Total:71  Current:70    [First] [Prev] [Next] [Last]